-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains In-Line on Quest Diagnostics, Lowers Price Target to $210

Benzinga·04/08/2026 15:15:48
Listen to the news
Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Line and lowers the price target from $220 to $210.